Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

BAG3 Gene Myopathy (Myofibrillar Myopathy Type 6) Genetic Test in UAE | 2800 AED

Executive Summary & Core Metrics

  • Diagnostic Accuracy: 99.9% analytical sensitivity via ISO-accredited processing.
  • Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection (daily 8 AM–11 PM).
  • Post-Test Guidance: Telephonic consultation with a DHA-licensed genetic specialist included.
  • Insurance Verification: Direct WhatsApp check via +971 54 548 8731.

Test Overview & Methodology

The BAG3 Gene Myopathy (Myofibrillar Myopathy Type 6) NGS Test detects pathogenic mutations in the BAG3 gene that cause progressive neuromuscular disease with cardiac involvement. High-coverage Next-Generation Sequencing precisely identifies point mutations, small insertions/deletions, and copy-number variations, enabling a definitive genetic diagnosis in patients with suspected autosomal dominant or sporadic myofibrillar myopathy.

Methodology & Comparison

Parameter Our BAG3 NGS Test Standard (Sanger/Panel)
Precision99.9% analytical sensitivity (NGS + bioinformatics)Variable; may miss novel variants
MethodologyIllumina NovaSeq X Plus – full gene sequencingSanger sequencing (coding regions only)
Turnaround3–4 weeks (ISO cold‑chain)4–6 weeks
CoverageFull coding exons, exon‑intron boundaries, CNV detectionSelected exons, no CNV
UAE RegulatoryDHA/MOHAP approved, ISO 9001:2015Often non‑ISO

Physician Insight & Safety Protocols

“I am Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403). As a genetics specialist, I understand the emotional weight a genetic result carries. While this test provides molecular confirmation, it must always be correlated with your full clinical picture – including muscle imaging, electromyography, and cardiac evaluation. A gene variant alone never replaces a comprehensive medical assessment; our team is here to guide you every step.”

Advisory – Medication & Lifestyle

⚠️ Medication Reminder

Do not stop or adjust any prescribed medication without consulting your doctor. Genetic results may influence long‑term management, but never alter your current therapy unless under direct specialist supervision.

Exclusion Criteria & Red Flags

Pre-Test Exclusions

  • Testing of minors without explicit, documented guardian consent (per Federal Decree-Law No. 4 of 2016 on Medical Liability).
  • Individuals who have not received prior genetic counselling.
  • Poor‑quality DNA samples (hemolysed blood, insufficient quantity).

Emergency Red Flags – Seek Immediate Care

  • Sudden, severe muscle weakness or inability to walk
  • Unexplained chest pain, palpitations, or shortness of breath
  • Swallowing difficulties or respiratory distress

Patient FAQ & Clinical Guidance

1. What is the BAG3 gene and why is it tested?

The BAG3 gene provides instructions for a protein crucial for muscle cell stability; mutations cause myofibrillar myopathy type 6, a progressive muscle-wasting condition often affecting the heart. This NGS test detects those mutations to confirm the diagnosis, guide cardiac surveillance, and inform family members about their genetic risk.

2. How is the sample collected and what preparation is needed?

A simple blood draw (3 mL in EDTA), extracted DNA, or a single drop of blood on an FTA card is sufficient. Prior to scheduling, you must attend a pre‑test genetic counselling session to draw a detailed family pedigree and discuss the implications of possible results. No fasting or medication changes are required unless directed by your doctor.

3. When will I receive the results and who will explain them?

The standard turnaround time is 3 to 4 weeks from sample receipt. Results are delivered through our secure patient portal, and a telephonic post‑test guidance session with a DHA‑licensed genetic counsellor is included. Complex variants are reviewed by our multidisciplinary board before release.

UAE Regulatory & Data Privacy Adherence

  • Data Protection: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – all genetic data encrypted and access-controlled.
  • Health ICT Security: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – secure LIS and encrypted patient portal.
  • Clinical & Consent Safety: Aligned with Federal Decree-Law No. 4 of 2016 on Medical Liability – pre-test counselling and documented consent mandatory.
  • Accreditation: DHA licensed (No. 1143), ISO 9001:2015 certified (INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name BAG3 Gene Myopathy (Myofibrillar Myopathy Type 6) Genetic Test
Price (AED) 2,800
Turnaround Time 3–4 weeks from sample receipt (ISO cold-chain logistics)
Sample Type / Matrix Peripheral whole blood (EDTA), extracted DNA, or FTA card. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM.
Methodology Used Next-Generation Sequencing (NGS) on Illumina NovaSeq X Plus – full gene sequencing including exon-intron boundaries and CNV detection.
ICD-10-CM Code G71.09 (Other specified myotonic disorders), Z13.71 (Encounter for genetic testing)
LOINC Code 48019-2 (DNA sequencing for gene mutations)
DHA Facility License & Lab Address DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians